tiprankstipranks
Trending News
More News >
Akso Health Group Sponsored ADR (AHG)
NASDAQ:AHG
US Market

Akso Health Group Sponsored ADR (AHG) Ratios

Compare
149 Followers

Akso Health Group Sponsored ADR Ratios

AHG's free cash flow for Q4 2025 was $-0.06. For the 2025 fiscal year, AHG's free cash flow was decreased by $ and operating cash flow was $-0.43. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
14.20 39.52 1.78 1.32 2.09
Quick Ratio
14.18 39.46 1.64 1.12 3.09
Cash Ratio
12.76 23.70 0.68 0.57 1.05
Solvency Ratio
-8.41 -2.59 -1.12 -0.44 -2.19
Operating Cash Flow Ratio
0.09 0.38 -0.28 -0.22 0.70
Short-Term Operating Cash Flow Coverage
0.00 0.00 -0.34 0.00 1.01
Net Current Asset Value
$ 180.32M$ 138.42M$ 9.11M$ 12.23M$ 15.71M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 0.01 0.47 0.73 0.32
Debt-to-Equity Ratio
<0.01 0.01 1.11 3.03 0.58
Debt-to-Capital Ratio
<0.01 0.01 0.53 0.75 0.37
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.02 0.00 0.00
Financial Leverage Ratio
1.08 1.03 2.34 4.13 1.83
Debt Service Coverage Ratio
0.00 0.00 -1.47 -4.22 -0.21
Interest Coverage Ratio
0.00 0.00 0.00 -18.82 -12.60
Debt to Market Cap
0.00 0.00 3.65 0.00 1.05
Interest Debt Per Share
<0.01 0.10 0.42 1.91 0.75
Net Debt to EBITDA
99.34 0.00 -0.12 -4.68 2.48
Profitability Margins
Gross Profit Margin
-1.91%5.06%9.63%14.52%68.97%
EBIT Margin
-26.55%-376.57%-99.13%-50.77%-121.87%
EBITDA Margin
-12.00%0.00%-108.09%-51.66%-118.04%
Operating Profit Margin
-1125.37%-357.78%-108.23%-239.79%-1547.05%
Pretax Profit Margin
-1125.14%-376.57%-99.13%-264.90%-1770.39%
Net Profit Margin
-913.38%-391.78%-99.26%-266.99%-1797.92%
Continuous Operations Profit Margin
-1334.09%-377.61%-99.26%-64.98%-244.64%
Net Income Per EBT
81.18%104.04%100.13%100.79%101.55%
EBT Per EBIT
99.98%105.25%91.59%110.47%114.44%
Return on Assets (ROA)
-62.79%-6.66%-63.95%-33.25%-99.58%
Return on Equity (ROE)
-67.54%-6.84%-149.96%-137.17%-182.68%
Return on Capital Employed (ROCE)
-82.68%-6.24%-161.40%-123.18%-157.19%
Return on Invested Capital (ROIC)
-98.02%-6.26%-77.11%-124.15%-101.10%
Return on Tangible Assets
-68.78%-6.66%-63.95%-33.25%-99.58%
Earnings Yield
-30.98%-39.86%-483.55%-150.53%-330.37%
Efficiency Ratios
Receivables Turnover
1.15 0.00 1.71 0.32 0.17
Payables Turnover
0.00 0.00 0.00 0.00 0.00
Inventory Turnover
79.16 11.99 7.06 0.69 -0.04
Fixed Asset Turnover
129.01 0.00 0.00 113.85 26.24
Asset Turnover
0.07 0.02 0.64 0.12 0.06
Working Capital Turnover Ratio
0.08 0.03 1.24 0.45 0.06
Cash Conversion Cycle
323.12 30.45 264.80 1.68K -7.46K
Days of Sales Outstanding
318.51 0.00 213.13 1.16K 2.17K
Days of Inventory Outstanding
4.61 30.45 51.67 527.44 -9.63K
Days of Payables Outstanding
0.00 0.00 0.00 0.00 0.00
Operating Cycle
323.12 30.45 264.80 1.68K -7.46K
Cash Flow Ratios
Operating Cash Flow Per Share
<0.01 0.06 -0.14 -0.43 0.62
Free Cash Flow Per Share
<0.01 0.06 -0.14 -0.43 0.62
CapEx Per Share
<0.01 0.00 0.00 <0.01 0.00
Free Cash Flow to Operating Cash Flow
0.87 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
7.62 0.00 0.00 -1.78K 0.00
Capital Expenditure Coverage Ratio
7.62 0.00 0.00 -1.78K 0.00
Operating Cash Flow Coverage Ratio
14.40 0.68 -0.34 -0.23 1.01
Operating Cash Flow to Sales Ratio
0.08 0.56 -0.25 -1.37 5.73
Free Cash Flow Yield
0.14%1.90%-40.08%-25.71%35.11%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-3.23 -2.51 -0.21 -0.66 -0.30
Price-to-Sales (P/S) Ratio
48.68 9.83 0.21 1.77 5.44
Price-to-Book (P/B) Ratio
2.19 0.17 0.31 0.91 0.55
Price-to-Free Cash Flow (P/FCF) Ratio
703.48 17.56 -0.83 -1.30 0.95
Price-to-Operating Cash Flow Ratio
370.08 17.56 -0.83 -1.30 0.95
Price-to-Earnings Growth (PEG) Ratio
0.19 0.03 <0.01 0.01 <0.01
Price-to-Fair Value
2.19 0.17 0.31 0.91 0.55
Enterprise Value Multiple
-306.40 0.00 -0.31 -8.12 -2.13
Enterprise Value
543.30M -11.99M 9.88M 48.86M 23.52M
EV to EBITDA
-306.40 0.00 -0.69 -14.98 -11.36
EV to Sales
36.76 -4.97 0.75 7.74 13.40
EV to Free Cash Flow
531.24 -8.87 -3.04 -5.66 2.34
EV to Operating Cash Flow
461.54 -8.87 -3.04 -5.66 2.34
Tangible Book Value Per Share
0.54 6.65 0.39 0.62 1.06
Shareholders’ Equity Per Share
0.60 6.65 0.38 0.62 1.06
Tax and Other Ratios
Effective Tax Rate
-0.19 >-0.01 >-0.01 >-0.01 -0.02
Revenue Per Share
0.04 0.12 0.58 0.32 0.11
Net Income Per Share
-0.41 -0.45 -0.57 -0.85 -1.94
Tax Burden
0.81 1.04 1.00 1.01 1.02
Interest Burden
42.38 1.00 1.00 5.22 14.53
Research & Development to Revenue
0.00 0.00 >-0.01 0.07 0.31
SG&A to Revenue
0.25 3.56 1.18 2.44 15.54
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.06 0.03
Income Quality
>-0.01 -0.15 0.25 0.51 -0.29
Currency in USD